Association of ADIPOQ and ADIPOR variants with risk of colorectal cancer: A meta-analysis

  • Xuan Tan (谭 璇)
  • Guo-bin Wang (王国斌)
  • Yong Tang (唐 勇)
  • Jie Bai (白 洁)
  • Lin Ye (叶 霖)Email author


Numerous epidemiological studies have studied the association of adiponectin (ADIPOQ) gene and adiponectin receptor (ADIPOR) gene polymorphisms with risk of colorectal cancer (CRC), but the outcomes were incomplete and inconsistent. Therefore, we conducted a meta-analysis to assess the associations systematically. All eligible case-control studies published up to Jan. 2015 were searched from PubMed, the Cochrane library, Elsevier, Wiley Online library, China National Knowledge Infrastructure, WanFang data and Chongqing VIP. Effect sizes of odds ratio (OR) and 95% confidence interval (95%CI) were calculated by using a fixed- or random-effect model. Twelve case-control studies including 6141 cases and 7398 controls were selected. Significant differences in the distributions of allele frequency with CRC risk were directly present in ADIPOQ variants rs2241766, rs1501299 and ADIPOR variant rs1342387. In stratified analysis for different populations, significant differences were present in ADIPOQ variant rs822396 for Ashkenazi Jewish, in ADIPOQ variant rs1501299 and ADIPOR variant rs1342387 for Chinese and in ADIPOQ variant rs 2241766 for Ashkenazi Jewish and Chinese. In addition, the factors correlated with insulin resistance had synergistic effect with ADIPOQ variants rs2241766 T/G and rs1501299 G/T on risk of CRC. ADIPOQ variants rs2241766 T/G, rs1501299 G/T and ADIPOR variant ADIPOR rs1342387 G/A had a population specific correlation with CRC risk, which may be mediated by insulin resistance. And large well-designed studies are still needed for further evaluation of rs822396 and rs1063538, especially for their interaction and combined effect in the correlation with CRC risk.

Key words

adiponectin gene adiponectin receptor gene single nucleotide polymorphisms colorectal cancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer, 2007,7(10):763–777CrossRefPubMedGoogle Scholar
  2. 2.
    Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 2003,46(4):459–469CrossRefPubMedGoogle Scholar
  3. 3.
    Kim AY, Lee YS, Kim KH, et al. Adiponectin represses colon cancer cell proliferation via AdipoR1-and -R2-mediated AMPK activation. Mol Endocrinol, 2010,24(7):1441–1452CrossRefPubMedGoogle Scholar
  4. 4.
    Xu Y, He B, Pan Y, et al. The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. Mol Biol Rep, 2013,40(2):1135–1144CrossRefPubMedGoogle Scholar
  5. 5.
    Li Q, Ma Y, Sang W, et al. Five common haplotype-tagging variants of adiponectin (ADIPOQ) and cancer susceptibility: a meta-analysis. Genet Test Mol Biomarkers, 2014,18(6):417–424CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Fan HJ, Wen ZF, Xu BL, et al. Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis. Tumour Biol, 2013,34(2):769–778CrossRefPubMedGoogle Scholar
  7. 7.
    Ye C, Wang J, Tan S, et al. Meta-analysis of adiponectin polymorphisms and colorectal cancer risk. Int J Med Sci, 2013,10(9):1113–1120CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Li P, Liu H, Li C, et al. An updated meta-analysis of the association between ADIPOQ rs2241766 polymorphism and colorectal cancer. Tumour Biol, 2014,35(3):2491–2496CrossRefPubMedGoogle Scholar
  9. 9.
    Yu LX, Zhou NN, Liu LY, et al. Adiponectin receptor 1 (ADIPOR1) rs1342387 polymorphism and risk of cancer: a meta-analysis. Asian Pac J Cancer Prev, 2014,15(18):7515–7520CrossRefPubMedGoogle Scholar
  10. 10.
    Kaklamani VG, Wisinski KB, Sadim M, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA, 2008,300(13):1523–1531CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement. Genet Epidemiol, 2009,33(7):581–598CrossRefPubMedGoogle Scholar
  12. 12.
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002,21(11):1539–1558CrossRefPubMedGoogle Scholar
  13. 13.
    Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003,327(7414):557–560CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials, 1986,7(3):177–188CrossRefGoogle Scholar
  15. 15.
    Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med, 1987,6(3):341–350CrossRefPubMedGoogle Scholar
  16. 16.
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994,50(4):1088–1101CrossRefPubMedGoogle Scholar
  17. 17.
    Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ, 1997,315(7121):1533–1537CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Keku TO, Vidal A, Oliver S, et al. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control, 2012,23(7):1127–1138CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Hu X, Yuan P, Yan J, et al. Gene Polymorphisms of +45T>G, -866G>A, and Ala54Thr on the risk of colorectal cancer: a matched case-control study. PLoS One, 2013,8(6): e67275CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Li X, Liu W, Feng F, et al. Association between adiponectin rs2241766, rs1501299 polymorphisms and the risk of colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2014,35(2):195–199Google Scholar
  21. 21.
    Guo X, Liu J, You L, et al. Association between adiponectin polymorphisms and the risk of colorectal cancer. Genet Test Mol Biomarkers, 2015,19(1):9–13CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Pechlivanis S, Bermejo JL, Pardini B, et al. Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol, 2009,160(6):933–940CrossRefPubMedGoogle Scholar
  23. 23.
    Liu L, Zhong R, Wei S, et al. Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One, 2011,6(11):273015Google Scholar
  24. 24.
    Tsilidis KK, Helzlsouer KJ, Smith MW, et al. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control, 2009,20(9):1739–1751CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Gornick MC, Rennert G, Moreno V, et al. Adiponectin gene and risk of colorectal cancer. Br J Cancer, 2011,105(4):562–564CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Zhang Y, Feng QL, Liu CM, et al. Relationship between polymorphism sites of adiponection and it’s receptor gene and the susceptibility of colorectal cancer. Jiangsu Daxue Xuebao (Yixueban) (Chinese), 2012,22(4):336–341Google Scholar
  27. 27.
    Ou Y, Chen P, Zhou Z, et al. Associations between variants on ADIPOQ and ADIPOR1 with colorectal cancer risk: a Chinese case-control study and updated meta-analysis. BMC Med Genet, 2014,15(1):1375CrossRefGoogle Scholar
  28. 28.
    Partida-Perez M, de la Luz Ayala-Madrigal M, Peregrina-Sandoval J, et al. Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark, 2010,7(3):117–121CrossRefPubMedGoogle Scholar
  29. 29.
    Al-Harithy RN, Al-Zahrani MH. The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett, 2012,3(1):176–180PubMedGoogle Scholar
  30. 30.
    Gialamas SP, Petridou ET, Tseleni-Balafouta S, et al. Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism, 2011,60(11):1530–1158CrossRefPubMedGoogle Scholar
  31. 31.
    Gonzalez-Sanchez JL, Zabena CA, Martinez-Larrad MT, et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res, 2005,13(5):807–812CrossRefPubMedGoogle Scholar
  32. 32.
    He B, Pan Y, Zhang Y, et al. Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet, 2011, 12: 94CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Yoon YS, Keum N, Zhang X, et al. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis. Metabolism, 2015,64(10):1324–1333CrossRefPubMedGoogle Scholar
  34. 34.
    Melistas L, Mantzoros CS, Kontogianni M, et al. Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol, 2009,161(6):845–852CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Carvajal-Carmona LG, Spain S, Consortium C, et al. Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet, 2009,18(10):1889–1892CrossRefPubMedGoogle Scholar

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Xuan Tan (谭 璇)
    • 1
  • Guo-bin Wang (王国斌)
    • 2
  • Yong Tang (唐 勇)
    • 2
  • Jie Bai (白 洁)
    • 2
  • Lin Ye (叶 霖)
    • 2
    Email author
  1. 1.Department of Ophthalmology, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  2. 2.Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations